mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.02 |
mRNA |
nakiterpiosin |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.02 |
mRNA |
Bleomycin |
GDSC1000 |
pan-cancer |
AAC |
0.084 |
0.02 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.02 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.02 |
mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.02 |
mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.02 |
mRNA |
Tipifarnib |
GDSC1000 |
pan-cancer |
AAC |
0.081 |
0.02 |
mRNA |
Bryostatin 1 |
GDSC1000 |
pan-cancer |
AAC |
0.08 |
0.02 |
mRNA |
CID-5951923 |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.02 |